Synthetic biology production platform
Employees: 11-50
Total raised: $15M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | EQT Ventur... | eqtventure... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.05.2021 | - | $15M | - |
Mentions in press and media 2
| Date | Title | Description |
| 26.05.2021 | Origin.Bio Raises $15M in Funding | Origin.Bio, a Munich, Germany-based synthetic biology company, raised $15m in funding. The round was led by EQT Ventures with participation from existing investor BlueYard Capital and new investors Taavet Hinrikus and Sten Tamkivi, Acequia ... |
| 26.05.2021 | This Company Is Freeing Manufacturers From Petrochemicals With Biology | Jens Klein, founder and CEO of Origin.Bio.Origin.Bio |